Madrigal Pharmaceuticals IncNASDAQ:MDGL
- LAST PRICE279.3100
- TODAY'S CHANGE (%)-0.8500 (-0.3034%)
- Bid / Lots270.0000/ 1
- Ask / Lots288.8500/ 10
- Open / Previous Close277.0200 / 280.1600
- Day Range
- 52 Week Range
- Volume290,253
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MDGL |
|---|---|---|
| 09:32 ET | 1476 | 277.12 |
| 09:34 ET | 210 | 278.06 |
| 09:36 ET | 571 | 280.15 |
| 09:38 ET | 840 | 280 |
| 09:39 ET | 3075 | 282.05 |
| 09:41 ET | 1100 | 281.32 |
| 09:43 ET | 500 | 280.365 |
| 09:45 ET | 975 | 278.695 |
| 09:48 ET | 200 | 278.47 |
| 09:50 ET | 384 | 278.62 |
| 09:57 ET | 325 | 279.385 |
| 09:59 ET | 702 | 279.725 |
| 10:01 ET | 1221 | 279.89 |
| 10:03 ET | 513 | 279.19 |
| 10:06 ET | 200 | 278.505 |
| 10:08 ET | 300 | 279.12 |
| 10:10 ET | 720 | 278.445 |
| 10:12 ET | 817 | 278.635 |
| 10:14 ET | 1100 | 279.28 |
| 10:15 ET | 723 | 279.62 |
| 10:17 ET | 5230 | 279.52 |
| 10:19 ET | 1200 | 279.69 |
| 10:21 ET | 5551 | 279.685 |
| 10:24 ET | 200 | 279.315 |
| 10:26 ET | 500 | 279.215 |
| 10:28 ET | 1553 | 278.735 |
| 10:30 ET | 1740 | 279.21 |
| 10:32 ET | 700 | 279.71 |
| 10:33 ET | 1700 | 280.015 |
| 10:35 ET | 2200 | 280.03 |
| 10:37 ET | 200 | 279.915 |
| 10:39 ET | 500 | 280.08 |
| 10:42 ET | 901 | 279.2 |
| 10:44 ET | 100 | 279.63 |
| 10:46 ET | 100 | 279.01 |
| 10:48 ET | 416 | 279.26 |
| 10:50 ET | 500 | 278.82 |
| 10:51 ET | 562 | 279.98 |
| 10:53 ET | 2000 | 279.815 |
| 10:55 ET | 1100 | 279.9 |
| 11:00 ET | 500 | 280 |
| 11:02 ET | 794 | 280.3686 |
| 11:04 ET | 600 | 280.06 |
| 11:06 ET | 800 | 280.145 |
| 11:08 ET | 400 | 279.945 |
| 11:09 ET | 500 | 280.06 |
| 11:11 ET | 13316 | 280.015 |
| 11:13 ET | 948 | 279.785 |
| 11:15 ET | 400 | 279.875 |
| 11:18 ET | 3500 | 281.815 |
| 11:20 ET | 2664 | 281.535 |
| 11:24 ET | 1700 | 281.855 |
| 11:27 ET | 100 | 281.82 |
| 11:29 ET | 1792 | 280 |
| 11:31 ET | 100 | 279.07 |
| 11:33 ET | 417 | 278.07 |
| 11:36 ET | 200 | 278.26 |
| 11:40 ET | 100 | 278.48 |
| 11:42 ET | 500 | 278.435 |
| 11:47 ET | 200 | 278.355 |
| 11:51 ET | 100 | 278.67 |
| 12:02 ET | 200 | 278.705 |
| 12:03 ET | 600 | 278.285 |
| 12:05 ET | 200 | 278.72 |
| 12:07 ET | 500 | 278.89 |
| 12:09 ET | 350 | 278.44 |
| 12:12 ET | 2302 | 279 |
| 12:16 ET | 2261 | 278.55 |
| 12:21 ET | 232 | 278.1601 |
| 12:23 ET | 100 | 278.6 |
| 12:25 ET | 900 | 277.642 |
| 12:30 ET | 100 | 277.8983 |
| 12:32 ET | 800 | 277.7859 |
| 12:34 ET | 400 | 277.55 |
| 12:36 ET | 500 | 276.9101 |
| 12:39 ET | 300 | 277.37 |
| 12:41 ET | 500 | 277.845 |
| 12:45 ET | 100 | 277.71 |
| 12:52 ET | 100 | 278.02 |
| 12:56 ET | 600 | 277.53 |
| 12:59 ET | 200 | 277.325 |
| 01:01 ET | 100 | 277.37 |
| 01:03 ET | 100 | 276.87 |
| 01:06 ET | 600 | 277.565 |
| 01:08 ET | 100 | 277.51 |
| 01:12 ET | 100 | 277.81 |
| 01:17 ET | 300 | 277.525 |
| 01:21 ET | 100 | 277.665 |
| 01:26 ET | 200 | 277.88 |
| 01:33 ET | 100 | 277.84 |
| 01:35 ET | 206 | 277.46 |
| 01:37 ET | 100 | 277.775 |
| 01:39 ET | 337 | 277.4221 |
| 01:42 ET | 807 | 277.05 |
| 01:48 ET | 400 | 276.925 |
| 01:50 ET | 200 | 277.3 |
| 01:55 ET | 1000 | 277.85 |
| 02:00 ET | 500 | 278.099 |
| 02:02 ET | 3149 | 278.185 |
| 02:04 ET | 100 | 278.395 |
| 02:06 ET | 408 | 278.95 |
| 02:08 ET | 300 | 278.81 |
| 02:09 ET | 300 | 279.21 |
| 02:11 ET | 200 | 279.805 |
| 02:13 ET | 1500 | 280 |
| 02:15 ET | 2493 | 280.17 |
| 02:18 ET | 200 | 280.185 |
| 02:20 ET | 200 | 280.215 |
| 02:22 ET | 205 | 280.56 |
| 02:24 ET | 100 | 280.195 |
| 02:26 ET | 600 | 279.81 |
| 02:27 ET | 1000 | 279.905 |
| 02:29 ET | 100 | 279.885 |
| 02:31 ET | 319 | 279.86 |
| 02:33 ET | 100 | 279.97 |
| 02:36 ET | 800 | 280.21 |
| 02:38 ET | 600 | 279.925 |
| 02:40 ET | 1700 | 280.04 |
| 02:45 ET | 200 | 279.66 |
| 02:47 ET | 500 | 279.815 |
| 02:51 ET | 100 | 279.54 |
| 02:54 ET | 100 | 280.025 |
| 02:58 ET | 15556 | 280.645 |
| 03:00 ET | 400 | 281.8099 |
| 03:02 ET | 600 | 280.81 |
| 03:14 ET | 500 | 280.925 |
| 03:18 ET | 300 | 280.56 |
| 03:20 ET | 200 | 280.68 |
| 03:23 ET | 100 | 280.69 |
| 03:27 ET | 900 | 280.09 |
| 03:30 ET | 200 | 280.04 |
| 03:32 ET | 200 | 279.72 |
| 03:34 ET | 200 | 280.32 |
| 03:38 ET | 2953 | 279.08 |
| 03:39 ET | 100 | 279.305 |
| 03:41 ET | 669 | 279 |
| 03:43 ET | 2000 | 279.945 |
| 03:45 ET | 200 | 280.395 |
| 03:48 ET | 700 | 279.9 |
| 03:50 ET | 830 | 279.965 |
| 03:52 ET | 300 | 279.82 |
| 03:54 ET | 1600 | 280.08 |
| 03:56 ET | 2284 | 279.975 |
| 03:57 ET | 3715 | 279.805 |
| 03:59 ET | 6130 | 279.31 |
Jun 11, 2024
DJ Madrigal Pharmaceuticals Initiated at Outperform by Wolfe Research, from 2:48PM ET on Tuesday Jun 11, 2024 by Dow Jones
2:48PM ET on Tuesday Jun 11, 2024 by Dow Jones
Jun 6, 2024
Jun 5, 2024
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference, from 8:00AM ET on Wednesday Jun 05, 2024 by Dow Jones
8:00AM ET on Wednesday Jun 05, 2024 by Dow JonesDJ S&P 500 Futures Rise In Premarket Trading; Hewlett Packard Ent, CrowdStrike Holdings Lead, from 7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
7:30AM ET on Wednesday Jun 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Madrigal Pharmaceuticals Inc | 6.0B | -12.1x | --- |
Viking Therapeutics Inc | 5.8B | -59.5x | --- |
Cytokinetics Inc | 6.3B | -10.1x | --- |
Summit Therapeutics Inc | 5.5B | -49.1x | --- |
Revolution Medicines Inc | 6.4B | -10.3x | --- |
Krystal Biotech Inc | 5.2B | 96.8x | --- |
Company Information
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Contact Information
- Headquarters
- 200 Barr Harbor Dr Ste 400WEST CONSHOHOCKEN, PA, United States 19428-2978
- Phone
- 404-380-9263
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Julian Baker
- President, Chief Executive Officer, Director
- Bill Sibold
- Chief Financial Officer, Senior Vice President
- Mardi Dier
- President of Research and Development, Chief Medical Officer, Director
- Rebecca Taub
- Chief Commercial Officer
- Carole Huntsman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.0B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 21.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.42 |
EPS | $-23.08 |
Book Value | $20.39 |
P/E Ratio | -12.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
